Protalix BioTherapeutics ... (PLX)
AMEX: PLX
· Real-Time Price · USD
1.52
-0.02 (-1.30%)
At close: Aug 19, 2025, 3:59 PM
1.55
1.64%
After-hours: Aug 19, 2025, 06:15 PM EDT
-1.30% (1D)
| Bid | 1.46 |
| Market Cap | 121.56M |
| Revenue (ttm) | 59.76M |
| Net Income (ttm) | 3.91M |
| EPS (ttm) | 0.09 |
| PE Ratio (ttm) | 16.94 |
| Forward PE | 3.41 |
| Analyst | Strong Buy |
| Ask | 1.55 |
| Volume | 618,983 |
| Avg. Volume (20D) | 829,633 |
| Open | 1.53 |
| Previous Close | 1.54 |
| Day's Range | 1.47 - 1.55 |
| 52-Week Range | 0.89 - 3.10 |
| Beta | -0.21 |
Analyst Forecast
According to 0 analyst ratings, the average rating for PLX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
Protalix BioTherapeutics Inc. is scheduled to release its earnings on
Nov 13, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
3 months ago
-40.48%
Protalix BioTherapeutics shares are trading lower ...
Unlock content with
Pro Subscription
5 months ago
+9.38%
Protalix BioTherapeutics shares are trading higher after the company reported a FY 2024 GAAP EPS beat.
5 days ago · proactiveinvestors.com
Protalix BioTherapeutics lifts revenue on strong Elfabrio demandProtalix Biotherapeutics Inc (NYSE-A:PLX) reported higher quarterly revenue and reaffirmed its long-term growth outlook on Thursday, pointing to expanding demand for its Fabry disease treatment Elfabr...
1 month ago · proactiveinvestors.com
Protalix BioTherapeutics joins Russell 3000 and 2000 indexes following annual reconstitutionProtalix Biotherapeutics Inc (NYSE-A:PLX) announced that it has been added to the Russell 3000 and Russell 2000 Indexes, effective after the US market closed on Friday, June 27. The inclusion follows...